fig6

Figure 6. Immunohistochemical markers representative of phenotypic correlates of dysregulated molecular pathways: TP53 (A), PD1 in immune cells (B), PDL1 in tumour cells (C), CK19 in tumour cells (D), β-catenin nuclear positivity (E), glutamine synthetase diffuse expression (F). PD1: Programmed death-1; PD-L1: programmed death-ligand 1